Pyridazines for use in treating fungal infections, pharmaceutical compositions containing them, and processes for their preparation
申请人:Pfizer Limited
公开号:EP0014562A1
公开(公告)日:1980-08-20
Pharmaceutical compositions in unit dosage form comprising a compound of the formula:
wherein R is H, C1-C4 alkyl,-CH2CH2(C1-C4 alkoxy) or benzyl; or a zinc complex thereof, or an alkali metal salt of said compound or complex, together with a pharmaceutically acceptable diluent or carrier. Also included are the compounds of the formula (I) or (II), or their zinc complexes or alkali metal salts, for use in treating a fungal infection in a human being. The zinc complexes of the formulae (I) and (II), and the compounds of the formula (I) and (II) and their alkali metal salts, in which R is C2-C4 alkyl, -CH2CH2(C1-C4 alkoxy) or benzyl, are claimed per se; also claimed are processes for their preparation and pharmaceutical compositions containing them.
单位剂型的药物组合物,包含式中化合物:
其中 R 为 H、C1-C4 烷基、-CH2CH2(C1-C4 烷氧基)或苄;或其锌络合物,或所述化合物或络合物的碱金属盐,连同药学上可接受的稀释剂或载体。还包括用于治疗人类真菌感染的式 (I) 或 (II) 化合物或其锌络合物或碱金属盐。式(Ⅰ)和(Ⅱ)的锌络合物、式(Ⅰ)和(Ⅱ)的化合物及其碱金属盐,其中R为C2-C4烷基、-CH2CH2(C1-C4烷氧基)或苄基,其本身已提出权利要求;还提出了制备它们的工艺和含有它们的药物组合物的权利要求。